معرفی
Robert Berger is a Clinical Assistant Professor in Psychiatry at Yale School of Medicine, affiliated with the Connecticut Mental Health Center. He holds an MD from New York University School of Medicine (1976). His research focuses on cancer biology, organoid modeling, and clinical trials, particularly in breast and renal cell carcinoma. His work explores drug development, molecular mechanisms of cancer progression, and therapeutic strategies like immunotherapy and targeted agents. Berger has contributed to studies on postoperative outcomes in cardiac surgery, healthcare disparities, and surgical team dynamics. His publications highlight collaborations in oncology, perioperative care, and translational medicine.
Education:
- MD, New York University School of Medicine (1976)
Research Interests: Berger’s research emphasizes cancer biology, organoid-based models of epithelial-mesenchymal transition, and drug responsiveness. He investigates therapeutic agents like PPARγ agonists and MEK inhibitors, alongside immunotherapies such as avelumab. His work bridges laboratory findings to clinical applications, addressing unmet needs in oncology and surgical care.
Advising & Grants: No specific advising or grant information provided in the text.
Labs & Teams: Likely affiliated with cancer research groups at Yale School of Medicine, though specific lab affiliations are not explicitly mentioned.